AN AMERICAN, A CANADIAN AND FRENCHMAN WIN THE 2011 NOBEL PRIZE FOR MEDICINE FOR RESEARCH INTO CANCERS AND THE IMMUNITY SYSTEM

Today’s Nobel Prize in Physiology or Medicine honors work in immunology that provides new avenues for prevention and therapy against infections, cancer, and inflammatory disease.

The Prize is shared by three researchers who have “revolutionized our understanding of the immune system” by discovering the “gatekeepers” of this integral defense mechanism, according to the Nobel Assembly’s press release.

 

Three doctors share the 2011 Nobel Prize for Physiology or Medicine for their research into vaccines that attack tumors just days after one of the winners, 68-year-old doctor Ralph Steinman, died of cancer. (Video: Reuters)

• Jules Hoffmann, a Luxembourgian based at the University of Strasbourg in France, and Bruce Beutler, an American at Scripps Research Institute in California, share half of the award for discovering receptor proteins that recognize microbes and activate innate immunity. 
• Ralph Steinman, a Canadian cell biologist at Rockefeller University, took the other half of the award for first describing the immune system’s dendritic cells and their role in activating and regulating adaptive immunity, the later stage of immune response responsible for clearing microorganisms from the body. Sadly, Steinman passed away last Friday (September 30), before he got word of his crowning achievement.

Dr Ralph A. Steinman (Canada)

Steinman’s “greatest contribution was that he himself really generated the field of dendritic cell biology,” Gerold Schuler, head of the department of dermatology at the University Hospital Erlangen in Germany and Steinman’s former post-doc, told The Scientist in an email.  Schuler notes.

"There is no doubt that Steinman’s work was worthy of a Nobel. The insights Steinman made into dendritic cell biology are now crucial to understanding and fighting diseases, notably for designing better vaccines.”

Dr. Jules A. Hoffman (France)

Hoffmann and Beutler’s work focuses on the first line of defense that destroys invading microbes and triggers inflammation to ward off bacterial, viral, or fungal enemies. In 1996 Hoffmann and colleagues made a pioneering discovery while investigating Drosophila with different mutations in Toll, a gene associated with embryonic development. When the mutant flies were infected with bacteria or fungi, Hoffmann noticed that they could not mount an adequate immune defense, and quickly died as a result. His observations led him to conclude that the Toll gene product helped sense pathogenic microorganisms and that Toll activation was needed in order to mount defense against the microbial invaders.

Dr. Bruce A. Beutler (US)

In 1998, Beutler extended his findings to mammals. While searching for receptors related to the bacterial product lipopolysaccharide (LPS) that causes septic shock, a potentially fatal over-stimulation of the immune system, Beutler and his colleagues observed that mice with mutations in a gene quite similar to that in the fruit fly’s Toll gene were resistant to shock. The gene turned out to encode the Toll-like LPS receptor, which binds bacterial LPS, resulting in the initiation of an innate immune response. In excess, however, that inflamma-tion can lead to septic shock. Mice with mutant LPS receptors failed to bind LPS and thus never succumbed to shock.

Toll Gene's role in activating the human immunity system

Beutler’s work is a rare example of truly exploratory research, said Alexander Poltorak, a mouse geneticist at Tufts University and the lead author on Beutler’s groundbreaking 1998 Science paper describing LPS signaling and gene mutations.  Poltorak, a former postdoc in Beutler’s lab said. 

“We didn’t have any hypothesis, and that’s the beauty of it.  Beutler absolutely deserves the Nobel for the research."  

Poltorak noted the many subsequent discoveries made possible by Beutler’s work. In the past 12 years, for example, scientists have reported about a dozen discoveries of various Toll-like receptors in humans and mice, each of which recognizes certain types of microbial molecules. Mutations in any of these receptors can increase the risk of infections or chronic inflammatory disease.

Steinman’s portion of this year’s Nobel focuses on a different part of the immune system—adaptive immunity, which occurs when microorganisms make it through innate immunity’s first line of defense. The adaptive immune system involves the production of antibodies and killer cells that seek out and destroy infected cells. The adaptive immune system stores immunologic memory for rapid defense mobilization if the same microbes invade in the future.

An immune system dentritic cell

In 1973, Steinman discovered a new immune cell type present in tissues in contact with the external environment, like skin, that he coined the dendritic cell. He showed in cell culture experiments that the presence of dendritic cells elicited in vivid T cell response to foreign substances, indicating their importance in the adaptive immune response. At first, these findings were met with skepticism by the scientific community, but Steinman’s follow-up work put any remaining doubts to rest, conclusively demonstrating that dendritic cells have a unique capacity for T cell activation and play a key role “in conducting the immune orchestra,” Schuler said.

Click Image To Enlarge

Steinman “was stubborn and brave enough to continue working on dendritic cells even though his work was largely ignored—to say the least—for the first 10 years,” said Schuler, who co-authored Steinman’s description of dendritic cell maturation first published in the Journal of Experimental Medicine in 1985. The work led to “an explosion” of research in the field of dendritic cells, Schuler added, and eventually brought the discovery into the clinic.

The Power of Dendritic Cells

In fact, Steinman’s own life was extended using a dendritic cell-based immunotheraphy of his own design. But the immunologist finally lost his battle with pancreatic cancer last week, just three days before his Nobel achievement was announced.  Steinman’s daughter Alexis in a statement issued by Rockefeller University said. 

“We are so touched that our father’s many years of hard work are being recognized with a Nobel Prize.  He devoted his life to his work and his family, and he would be truly honored.” 

Schuler said of his former mentor.

“Ralph has changed my life in many ways. [He was a] deeply caring and understanding human being…. I am very sad that he passed away, notably without having the chance to enjoy becoming a Nobel Laureate.”

COMMENTARY:   It's ironic that these three researchers were working on better vaccines to help fight cancerous tumors like the pancreatic cancer tumor that took Steve Job's life, and strengthening the body's immunity system.

I am especially impressed with the work of Dr. Steinman, who sadly died from pancreatic cancer only three days before the Nobel Prize announcement.  His research on the human body's immunity system goes back to 1973, and was largely ignored until it was published by his student mentoree in 1985.  It took 38 years for Dr. Steinman to receive his Nobel Prize, albeit post-humously.  What an incredible story.   

Those dentritic cells are scary looking with all those tenticles.  They remind a lot of those squid-like robotic things with those long tenticles in the Matrix movies.

I am proud to see that Dr. Bruce Beutler shared the Nobel Prize for Medicine with the Frenchman Dr. Jules Hoffman for their work in discovering receptor proteins that recognize microbes and activate innate immunity.  

Congrats to all of them for their contribution in the field of medicine.

Courtesy of an article dated October 3, 2011 appearing in The Scientist and an article dated October 3, 2011 appearing in MSNBC's Today Health

Comments

[kirkland dermatology]

You mention truth issue on that stuff. I think you described it in a professional way. I hope you go further in this way, with your excellent way of writing articles.

[buy meizitang]

So proud of them. Keep it on that level.

[Tommy]

Leona, Yes, I really enjoyed reporting on the three Nobel prize winners for physics. Very talented guys.

[Leona]

Pretty interesting and useful article and video!!! Thanks for letting me know about this stuff. There are much food to think over it.